1. Early tumor response to induction chemotherapy or chemoradiotherapy is a significant prognostic predictor in patients with initially unresectable T4 esophageal cancer following subsequent surgery
    Hideaki Shimoji et al, 2015, Esophagus CrossRef
  2. Surgery for malignant pulmonary nodules in patients with a history of oesophageal cancer
    Ryu Kanzaki et al, 2016, Interactive CardioVascular and Thoracic Surgery CrossRef
  3. Treatment Response to Neoadjuvant Therapy in Squamous Esophageal Cancer—Correlation Between Metabolic Response and Histopathology
    Abdeali Saif Arif Kaderi et al, 2024, Journal of Gastrointestinal Cancer CrossRef
  4. Three-Course Neoadjuvant Chemotherapy Associated with Unfavorable Survival of Non-responders to the First Two Courses for Locally Advanced Esophageal Cancer
    Yuto Kubo et al, 2023, Annals of Surgical Oncology CrossRef
  5. Outcomes of Neoadjuvant Chemoradiation in Patients with Gastro-esophageal Junction Adenocarcinoma: a Retrospective Cohort Study in Iran
    Farshid Farhan et al, 2019, Journal of Gastrointestinal Cancer CrossRef
  6. Clinical outcomes according to the modified endoscopic criteria for neoadjuvant chemotherapy in resectable esophageal squamous cell carcinoma
    Tomohiro Kadota et al, 2020, Digestive Endoscopy CrossRef
  7. Influence of incomplete neoadjuvant chemotherapy on esophageal carcinoma
    Yushi Fujiwara et al, 2018, International Journal of Clinical Oncology CrossRef
  8. Alpha linolenic acid and oleic acid additively down-regulate malignant potential and positively cross-regulate AMPK/S6 axis in OE19 and OE33 esophageal cancer cells
    Hyun-Seuk Moon et al, 2014, Metabolism CrossRef
  9. MiR-328 suppresses the survival of esophageal cancer cells by targeting PLCE1
    Na Han et al, 2016, Biochemical and Biophysical Research Communications CrossRef
  10. Neoadjuvant chemotherapy with irinotecan and nedaplatin in a single cycle followed by esophagectomy on cT4 resectable esophageal squamous cell carcinoma: a prospective nonrandomized trial for short-term outcomes
    D Tian et al, 2019, Diseases of the Esophagus CrossRef
  11. Utility of Initial Tumor Reduction as a Prognostic Factor in Esophageal Squamous Cell Cancer Patients Undergoing Neoadjuvant Chemotherapy Followed by Surgery
    Takaomi Hagi et al, 2024, Annals of Surgical Oncology CrossRef